Amlodipine

País: Nova Zelândia

Língua: inglês

Origem: Medsafe (Medicines Safety Authority)

Ingredientes ativos:

Amlodipine besilate 13.888mg equivalent to 10 mg Amlodipine

Disponível em:

Norton Healthcare Limited (NZ)

DCI (Denominação Comum Internacional):

Amlodipine besilate 13.888 mg (equivalent to 10 mg Amlodipine)

Dosagem:

10 mg

Forma farmacêutica:

Tablet

Composição:

Active: Amlodipine besilate 13.888mg equivalent to 10 mg Amlodipine Excipient: Calcium hydrogen phosphate Magnesium stearate Microcrystalline cellulose Sodium starch glycolate

Unidades em pacote:

Blister pack, Aluminium / PVC / PVdC, 30 tablets, 30 tablets

Classe:

Prescription

Tipo de prescrição:

Prescription

Fabricado por:

Dr Reddy's Laboratories Limited

Resumo do produto:

Package - Contents - Shelf Life: Blister pack, Aluminium / PVC / PVdC, 30 tablets - 30 tablets - 5 years from date of manufacture stored at or below 25°C

Data de autorização:

2008-06-13

Características técnicas

1
NEW ZEALAND DATA SHEET
1 PRODUCT NAME
Vasorex
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Amlodipine besilate 2.5 mg, 5 mg and 10 mg tablets
3 PHARMACEUTICAL FORM
Vasorex 2.5 mg tablets are white to off white, round with “C”
debossed on one side and
“126” on the other side. Alternatively, they are debossed on one
side with “3235” and
“WPI” on the other side. Each tablet contains amlodipine besilate
equivalent to 2.5 mg of
amlodipine.
Vasorex 5 mg tablets are white to off white, round with “C”
debossed on one side and
“127” on the other side. Alternatively, they are debossed on one
side with “3236” and
“WPI” on the other side. Each tablet contains amlodipine besilate
equivalent to 5 mg
amlodipine.
Vasorex 10 mg tablets are white to off white, round with “C”
debossed on one side and
“128” on the other side. Alternatively, they are debossed on one
side with “3237” and
“WPI” on the other side. Each tablet contains amlodipine besilate
equivalent to 10 mg
amlodipine.
Do not halve the tablet as dose equivalence when the tablet is divided
has not been
established.
4 CLINICAL PARTICULARS
4.1 Therapeutic indications
Vasorex is indicated for the first line treatment of hypertension and
can be used as the
sole agent to control blood pressure in the majority of patients.
Patients not adequately
controlled on a single antihypertensive agent may benefit from the
addition of amlodipine,
which has been used in combination with a thiazide diuretic, beta
adrenoceptor blocking
agent, or an angiotensin-converting enzyme inhibitor.
Vasorex is indicated for the first line treatment of myocardial
ischaemia, whether due to
fixed obstruction (stable angina) and/or vasospasm/vasoconstriction
(Prinzmetal's or
variant angina) of coronary vasculature.
Vasorex
may
be
used
where
the
clinical
presentation
suggests
a
possible
vasospastic/vasoconstrictive component but where
vasospasm/vasoconstriction has not
been confirmed. Vasorex may be used alone as monotherapy, or in
combination with other
anti